Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Kindbody"


13 mentions found


Kindbody, last valued at $1.8 billion, is pitching early-stage investors in its latest fundraising. The startup is offering a discount to investors in the round, according to multiple sources. The fertility company was reportedly burning through cash last year. Kindbody's fundraising push is getting complex as the fertility unicorn dangles discounts to potential investors to secure new cash, Business Insider has learned. Now, Kindbody has been forced to broaden its investor outreach and has pitched multiple early-stage VCs, according to two people with knowledge of the effort.
Persons: Kindbody Organizations: Business, Bloomberg
Investors rely on "exits" such as initial public offerings when assigning valuations to similar companies, Farr said. So the lack of attractive data on this front is helping to hold back the women's health category as a whole, she said. "Depressed valuations are keeping the IPO window latched," the authors of the SVB report wrote. Maven ClinicWomen's health, long neglected by VCs, is gaining tractionHistorically, investment in women's health has lagged behind other parts of healthcare. More than 76% of women's health startups have at least one female cofounder, the SVB report said.
Persons: Chrissy Farr, Farr, Maven, Kate Ryder, SVB, Gina Bartasi Organizations: OMERS Ventures, Silicon Valley Bank, Business, Maven
Fertility rates are declining, with those trying for children often needing access to reproductive tech. Insider spoke to seven VCs who named the top startups innovating reproductive and fertility services. "While it is difficult to pin just one number to the size of Europe's reproductive and fertility tech sector, there has definitely been significant growth across the market," said Sasha Astafyeva, partner at Atomico. In 2021, investors poured a record $3.76 billion into reproductive tech startups globally, per Pitchbook data. Insider asked seven VCs about the reproductive and fertility technology startups set to take off.
Persons: Camila Caso, Sasha Astafyeva, Peter Thiel, , Roe, Wade, Caso Organizations: World Health Organization, Founders Locations: Mexico, Atomico, Europe, Asia
watch nowWhy gay male couples face higher costsAlon Rivel, left, with his family. Gay male couples typically face a more expensive journey, as surrogacy or adoption are their primary choices. Employer fertility benefits offer limited helpMore employers are starting to offer fertility benefits, often through a specialized fertility benefits manager like Kindbody, Carrot, Progyny or Maven. But while more companies are offering fertility benefits, many of these packages are limited when it comes to covering what's needed to build families with non-traditional methods. At Rivel's insistence, he asked his human resources department to look into including surrogacy benefits.
Persons: Alon Rivel, Alon Rivel Alon Rivel, Rivel, Betsy Campbell, Maven, Will Porteous, Doug, Walter ., Porteous, Progyny's, Pete Anevski, Tammy Sun, Taryn Branca, they'll, Anevski, it's, Resolve's Campbell, Hanna, Stephen Hanna, Bret Shuford, Maverick Organizations: International Foundation of Employee, Equality, Mercer, Maven, Beam Therapeutics, Child Welfare Locations: Arlington , Massachusetts, U.S, Wynnewood , Pennsylvania, West, Massachusetts
Fertility companies are thriving as the rest of the healthcare industry stumbles. Many healthcare companies have seen their growth stunted by the market downturn, but fertility startups are defying the odds. Alessia Pierdomenico/Reuters Big returnsProgyny's success this year is boosting investor sentiment for private fertility companies, F-Prime Capital partner Carl Byers said. And some fertility companies are trying to stand out further by saying they can lower costs for employers. Experts predicted the fertility industry will see further consolidation this year, including more clinic acquisitions by private equity and by some fertility startups.
Persons: Kindbody, Scott Schoenhaus, Sarah James, Cantor Fitzgerald, PitchBook, Progyny, James, Alessia Pierdomenico, Carl Byers, Byers, Asima Ahmad, Carrot, Cantor Fitzgerald's James, Gina Bartasi, Peter Anevski, he's, Anevski, Rebecca Torrence Organizations: Morning, The Business Research Company, Investors, Reuters, Prime, Clinics, Maven, for Disease Control, Fertility
Meredith Whitney is back. Here's her latest market call
  + stars: | 2023-06-06 | by ( Jeff Cox | ) www.cnbc.com   time to read: +2 min
Famed analyst Meredith Whitney has ended a self-imposed exile from a finance world that she said had become "like watching paint dry." "Why I say there's no risk for an immediate downturn is because there's no forced selling," Whitney told CNBC's Sara Eisen during a " Squawk on the Street " interview. That forecast came after she had left Oppenheimer to start the Meredith Whitney Advisory Group, which she eventually shuttered to launch a hedge fund that no longer exists. Finance "was like watching paint dry, and things started to change about 18 months ago," Whitney said. In the current landscape, Whitney thinks the problems plaguing regional banks are collective "one-offs" that won't cause systemic damage.
Persons: Meredith Whitney, Whitney, CNBC's Sara Eisen, Oppenheimer Organizations: CNBC, Lehman, Citigroup, Meredith Whitney Advisory Group, Finance Locations: Silicon, Republic
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailKindbody founder Gina Bartasi on democratizing fertility treatment careGina Bartasi, founder and executive chair of Kindbody, joins 'The Exchange' to discuss the role of A.I. in fertility treatment, making fertility care more affordable, and Kindbody's growing partner network.
Pearson said that she expects to see more deals in women's health, orthopedics, cardiology, and kidney care, areas that remain largely unconsolidated today. She worked with Unified Women's Healthcare in its 2020 deal with Altas Partners and Ares Management. Last year, Unified Women's Healthcare acquired digital menopause provider platform Gennev. While some companies in these sectors are making deals to obtain more digital capabilities, others are investing internally in virtual capabilities. Kidney-care-focused companies U.S. Renal Care and DaVita are also investing in their virtual capabilities, she added.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThere is pent-up demand for fertility benefit services, says Kindbody's Gina BartasiGina Bartasi, founder and executive chair of Kindbody, joins 'Power Lunch' to discuss the company's effort to expand access to women's health clinics, Kindbody's recent $100 million dollar debt raise, and the impact slack in the labor market could have on fertility benefits market.
The multibillion dollar global fertility market is ripe with opportunity. For investors thinking about the fertility market, pharma firms may come to mind. In fact, the number of employers looking at fertility benefits as a "must have" has skyrocketed, she said. The global market size for fertility within the private women's health market should reach $72 billion by 2027, a report by FemTech Focus and Coyote Ventures found. Just like there were a wave of fintech companies going public, she expects fertility companies to eventually follow suit.
The company has made several big moves on telehealth, clinics healthcare research, and more. The Bentonville, Arkansas-based retailer announced in October the launch of the "Walmart Healthcare Research Institute," an institute geared toward helping underserved communities participate in clinical research. But Walmart has still faced significant challenges, from major leadership departures to a slower than expected rollout of healthcare clinics. Rolling out healthcare clinics nationwideA Walmart Health center. Launching a research institute for clinical trial participationWalmart is seeking to bolster clinical trial participation with its new healthcare research institute.
Walmart employees across the US will soon have access to dozens of fertility clinics. Fertility benefits are becoming a weapon in the war for talent, Fortune recently reported. In a Fortune poll, 45% of workers said fertility benefits are an important component when considering a new job. A fertility survey conducted by Carrot, a global fertility healthcare company, found that millennial and Generation Z employees value fertility benefits: 77% of respondents said that they would stay at a company if it offered fertility benefits, and a large majority of them said they would even consider changing jobs for better benefits. Mercer also has found that DEI values are a key motivation in expanding fertility benefits.
The startup's platform matches surrogate mothers with prospective parents they want to work with. Unlike traditional agencies, Nodal allows surrogate mothers to pick families they want to work with. Nodal is a surrogacy-matching platform that uses tech to connect surrogate mothers with prospective parents. Prospective parents pay $500 per month to join the platform for the first six months. Nodal is launching with 30 surrogates and six times as many prospective parents and hopes to grow its team in time.
Total: 13